MDRX News and Press, Allscripts Healthcare Solutions Inc. From 01/01/23

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Argus has upgraded Allscripts Healthcare Solutions ( NASDAQ: MDRX ) to buy from hold due to its growing Veradigm business and attractive valuation. The firm has a price target of $25 (35% upside based on Tuesday's close). Analyst David Coleman highlighted Allscripts' ( MDRX ) ...

Sphere's TrustCommerce® Healthcare Payments Platform Now Integrated with Veradigm® Practice Management PR Newswire Seamless integration enables providers using Veradigm ® Practice Management (formerly Allscripts Practice Management) to accept and post paymen...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Veradigm senior leadership to join board of directors Veradigm, a business unit of Allscripts (NASDAQ: MDRX), announced today The Point of Care Marketing Association (POCMA), a nonprofit organization to support the continued growth of the Point of Care (POC) channel thro...

The drug distribution space is probably too often overlooked by investors. In that domain, you have some central growth themes inextricably tied into the equation […] For further details see: Recession Proof Explosive Growth at Your Local Pharmacy? (CVS, DVLP, GDRX, WBA, RAD, MDR...

Summary The U.S. healthcare sector has a large industry with many challenges. Definitive Healthcare Corp. has the industry-leading platform. Definitive Healthcare Corp. has proprietary intelligence and data that serve as its competitive edge. Investment thesis I ...

Goldman Sachs has upgraded Allscripts Healthcare Solutions ( NASDAQ: MDRX ) to buy from hold saying that the healthcare IT solutions provider is exhibiting strong fundamental performance as it grows market share and controls costs. The firm upped its price target to $23 fr...

Supporting healthcare practices to successfully meet federal reporting requirements Veradigm, a business unit of Allscripts (NASDAQ: MDRX), announced today that Veradigm EHR (formerly known as Professional EHR) has achieved 2015 ONC Health IT Update Certification. This p...

Allscripts Healthcare Solutions press release ( NASDAQ: MDRX ): Q3 Non-GAAP EPS of $0.23 beats by $0.04 . Revenue of $151.9M (+5.0% Y/Y) misses by $0.89M . FY2022 Outlook : Veradigm revenue growth year-over-year between 6% to 7%; Veradigm Adjusted EBITDA gr...